HUTCHMED (China) Management
Management criteria checks 4/4
HUTCHMED (China)'s CEO is Wei-Guo Su, appointed in Jan 2012, has a tenure of 12.83 years. total yearly compensation is $2.45M, comprised of 32.5% salary and 67.5% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth €13.85M. The average tenure of the management team and the board of directors is 6.5 years and 7.7 years respectively.
Key information
Wei-Guo Su
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 32.5% |
| CEO tenure | 12.8yrs |
| CEO ownership | 0.5% |
| Management average tenure | 6.5yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$42m |
| Mar 31 2024 | n/a | n/a | US$29m |
| Dec 31 2023 | US$2m | US$798k | US$101m |
| Sep 30 2023 | n/a | n/a | US$36m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$195m |
| Dec 31 2022 | US$4m | US$700k | -US$361m |
| Sep 30 2022 | n/a | n/a | -US$308m |
| Jun 30 2022 | n/a | n/a | -US$255m |
| Mar 31 2022 | n/a | n/a | -US$235m |
| Dec 31 2021 | US$3m | US$395k | -US$195m |
| Sep 30 2021 | n/a | n/a | -US$187m |
| Jun 30 2021 | n/a | n/a | -US$178m |
| Mar 31 2021 | n/a | n/a | -US$151m |
| Dec 31 2020 | US$1m | US$346k | -US$126m |
| Sep 30 2020 | n/a | n/a | -US$117m |
| Jun 30 2020 | n/a | n/a | -US$110m |
| Mar 31 2020 | n/a | n/a | -US$102m |
| Dec 31 2019 | US$1m | US$274k | -US$106m |
| Sep 30 2019 | n/a | n/a | -US$93m |
| Jun 30 2019 | n/a | n/a | -US$87m |
| Mar 31 2019 | n/a | n/a | -US$83m |
| Dec 31 2018 | US$1m | US$273k | -US$75m |
| Sep 30 2018 | n/a | n/a | -US$72m |
| Jun 30 2018 | n/a | n/a | -US$61m |
| Mar 31 2018 | n/a | n/a | -US$39m |
| Dec 31 2017 | US$2m | US$310k | -US$27m |
Compensation vs Market: Wei-Guo's total compensation ($USD2.45M) is about average for companies of similar size in the German market ($USD1.92M).
Compensation vs Earnings: Wei-Guo's compensation has been consistent with company performance over the past year.
CEO
Wei-Guo Su (66 yo)
12.8yrs
Tenure
US$2,451,164
Compensation
Dr. Wei-Guo Su, B.Sc., Ph D., has been the Chief Executive Officer of HUTCHMED (China) Limited since March 04, 2022. Dr. Su has been the Chief Scientific Officer and Executive Vice President of HUTCHMED (C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 12.8yrs | US$2.45m | 0.49% € 13.8m | |
| CFO & Executive Director | 16.3yrs | US$962.15k | 0.18% € 5.1m | |
| Company Secretary & Non-Executive Director | 18.8yrs | no data | no data | |
| Executive VP & Head of Operations | less than a year | no data | no data | |
| Head of Investor Relations & Capital Strategies | no data | no data | no data | |
| Group General Counsel | 9.5yrs | no data | no data | |
| Senior Vice President of Corporate Management & Communications | 1.8yrs | no data | no data | |
| Senior Vice President of Global Human Resources | 2.8yrs | no data | no data | |
| Senior Vice President of Business Development & Strategic Alliances | no data | no data | no data | |
| Executive Vice President of Pharmaceutical Science & Manufacturing | 12.8yrs | no data | no data | |
| Senior Vice President of Global Quality | 3.6yrs | no data | no data | |
| Executive VP | 2.3yrs | no data | no data |
6.5yrs
Average Tenure
59yo
Average Age
Experienced Management: H7T2's management team is seasoned and experienced (6.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Scientific Officer & Executive Director | 7.7yrs | US$2.45m | 0.49% € 13.8m | |
| CFO & Executive Director | 13.8yrs | US$962.15k | 0.18% € 5.1m | |
| Company Secretary & Non-Executive Director | 18.8yrs | no data | no data | |
| Non-Executive Chairman | 8.3yrs | no data | 0.013% € 362.5k | |
| Non-Executive Director | 1.3yrs | no data | no data | |
| Independent Non-Executive Director | 7.7yrs | US$111.00k | 0.0053% € 151.0k | |
| Senior Independent Non-Executive Director | 7.8yrs | US$117.00k | 0.0087% € 244.9k | |
| Independent Non-Executive Director | 7.1yrs | US$114.86k | 0.011% € 316.4k | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | no data | no data | no data |
7.7yrs
Average Tenure
64.5yo
Average Age
Experienced Board: H7T2's board of directors are considered experienced (7.7 years average tenure).